Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $82.11 million. The enterprise value is $60.00 million.
| Market Cap | 82.11M |
| Enterprise Value | 60.00M |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, before market open.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 73.32 million shares outstanding. The number of shares has increased by 27.06% in one year.
| Shares Outstanding | 73.32M |
| Shares Change (YoY) | +27.06% |
| Shares Change (QoQ) | -15.64% |
| Owned by Insiders (%) | 14.58% |
| Owned by Institutions (%) | 12.99% |
| Float | 54.52M |
Valuation Ratios
The trailing PE ratio is 28.00 and the forward PE ratio is 5.28. PLX's PEG ratio is -0.10.
| PE Ratio | 28.00 |
| Forward PE | 5.28 |
| PS Ratio | 1.38 |
| Forward PS | 1.61 |
| PB Ratio | 2.76 |
| P/FCF Ratio | 18.79 |
| PEG Ratio | -0.10 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.22, with an EV/FCF ratio of 13.73.
| EV / Earnings | 8.76 |
| EV / Sales | 1.01 |
| EV / EBITDA | 6.22 |
| EV / EBIT | 7.13 |
| EV / FCF | 13.73 |
Financial Position
The company has a current ratio of 1.38, with a Debt / Equity ratio of 0.89.
| Current Ratio | 1.38 |
| Quick Ratio | 0.95 |
| Debt / Equity | 0.89 |
| Debt / EBITDA | 2.73 |
| Debt / FCF | 6.04 |
| Interest Coverage | 5.12 |
Financial Efficiency
Return on equity (ROE) is 19.50% and return on invested capital (ROIC) is 14.53%.
| Return on Equity (ROE) | 19.50% |
| Return on Assets (ROA) | 7.80% |
| Return on Capital (ROIC) | 14.53% |
| Revenue Per Employee | $286,798 |
| Profits Per Employee | $32,923 |
| Employee Count | 208 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 1.06 |
Taxes
| Income Tax | -79,000 |
| Effective Tax Rate | -1.17% |
Stock Price Statistics
The stock price has decreased by -39.13% in the last 52 weeks. The beta is 0.86, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | 0.86 |
| 52-Week Price Change | -39.13% |
| 50-Day Moving Average | 1.17 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 44.16 |
| Average Volume (20 Days) | 796,661 |
Short Selling Information
The latest short interest is 5.92 million, so 8.07% of the outstanding shares have been sold short.
| Short Interest | 5.92M |
| Short Previous Month | 6.26M |
| Short % of Shares Out | 8.07% |
| Short % of Float | 10.86% |
| Short Ratio (days to cover) | 19.08 |
Income Statement
In the last 12 months, PLX had revenue of $59.65 million and earned $6.85 million in profits. Earnings per share was $0.04.
| Revenue | 59.65M |
| Gross Profit | 37.16M |
| Operating Income | 8.06M |
| Pretax Income | 6.77M |
| Net Income | 6.85M |
| EBITDA | 9.65M |
| EBIT | 8.41M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $48.49 million in cash and $26.37 million in debt, giving a net cash position of $22.12 million or $0.30 per share.
| Cash & Cash Equivalents | 48.49M |
| Total Debt | 26.37M |
| Net Cash | 22.12M |
| Net Cash Per Share | $0.30 |
| Equity (Book Value) | 29.79M |
| Book Value Per Share | 0.41 |
| Working Capital | 20.58M |
Cash Flow
In the last 12 months, operating cash flow was $5.87 million and capital expenditures -$1.50 million, giving a free cash flow of $4.37 million.
| Operating Cash Flow | 5.87M |
| Capital Expenditures | -1.50M |
| Free Cash Flow | 4.37M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 62.28%, with operating and profit margins of 13.52% and 11.48%.
| Gross Margin | 62.28% |
| Operating Margin | 13.52% |
| Pretax Margin | 11.35% |
| Profit Margin | 11.48% |
| EBITDA Margin | 16.17% |
| EBIT Margin | 14.10% |
| FCF Margin | 7.32% |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -27.06% |
| Shareholder Yield | -27.06% |
| Earnings Yield | 8.34% |
| FCF Yield | 5.32% |
Analyst Forecast
The average price target for PLX is $10.00, which is 792.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $10.00 |
| Price Target Difference | 792.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |